Pharmacovigilance PV Outsourcing Market

Global Pharmacovigilance (PV) Outsourcing Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: Apr-2021 | Id: MACRC-58430 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Pharmacovigilance (PV) Outsourcing market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen

By Types:
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)

By Applications:
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue 1.5 Market Analysis by Type 1.5.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Contract Research Organizations (CROs) 1.5.3 Business Process Outsourcing (BPOs) 1.6 Market by Application 1.6.1 Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2022-2027 1.6.2 Premarketing Clinical Trial 1.6.3 Post-marketing Clinical Practice 1.6.4 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Pharmacovigilance (PV) Outsourcing Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Pharmacovigilance (PV) Outsourcing Market Players Profiles 3.1 Accenture 3.1.1 Accenture Company Profile 3.1.2 Accenture Pharmacovigilance (PV) Outsourcing Product Specification 3.1.3 Accenture Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 C3i Solutions 3.2.1 C3i Solutions Company Profile 3.2.2 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Specification 3.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Clintec 3.3.1 Clintec Company Profile 3.3.2 Clintec Pharmacovigilance (PV) Outsourcing Product Specification 3.3.3 Clintec Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Covance 3.4.1 Covance Company Profile 3.4.2 Covance Pharmacovigilance (PV) Outsourcing Product Specification 3.4.3 Covance Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Deloitte Touche Tohmatsu Limited 3.5.1 Deloitte Touche Tohmatsu Limited Company Profile 3.5.2 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Specification 3.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 ELC Group 3.6.1 ELC Group Company Profile 3.6.2 ELC Group Pharmacovigilance (PV) Outsourcing Product Specification 3.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Ergomed 3.7.1 Ergomed Company Profile 3.7.2 Ergomed Pharmacovigilance (PV) Outsourcing Product Specification 3.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 iGATE Corporation 3.8.1 iGATE Corporation Company Profile 3.8.2 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Specification 3.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 iMED Global Corporation 3.9.1 iMED Global Corporation Company Profile 3.9.2 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Specification 3.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 IQVIA 3.10.1 IQVIA Company Profile 3.10.2 IQVIA Pharmacovigilance (PV) Outsourcing Product Specification 3.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 MarksMan Healthcare 3.11.1 MarksMan Healthcare Company Profile 3.11.2 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Specification 3.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Medpace Holdings 3.12.1 Medpace Holdings Company Profile 3.12.2 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Specification 3.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Novartis 3.13.1 Novartis Company Profile 3.13.2 Novartis Pharmacovigilance (PV) Outsourcing Product Specification 3.13.3 Novartis Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Oracle Corporation 3.14.1 Oracle Corporation Company Profile 3.14.2 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Specification 3.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Parexel 3.15.1 Parexel Company Profile 3.15.2 Parexel Pharmacovigilance (PV) Outsourcing Product Specification 3.15.3 Parexel Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 PharmInvent 3.16.1 PharmInvent Company Profile 3.16.2 PharmInvent Pharmacovigilance (PV) Outsourcing Product Specification 3.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 PrimeVigilance 3.17.1 PrimeVigilance Company Profile 3.17.2 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Specification 3.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Pure Drug Safety 3.18.1 Pure Drug Safety Company Profile 3.18.2 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Specification 3.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 Sciformix 3.19.1 Sciformix Company Profile 3.19.2 Sciformix Pharmacovigilance (PV) Outsourcing Product Specification 3.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 SIRO Clinpharm 3.20.1 SIRO Clinpharm Company Profile 3.20.2 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Specification 3.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.21 Symogen 3.21.1 Symogen Company Profile 3.21.2 Symogen Pharmacovigilance (PV) Outsourcing Product Specification 3.21.3 Symogen Pharmacovigilance (PV) Outsourcing Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Pharmacovigilance (PV) Outsourcing Market Competition by Market Players 4.1 Global Pharmacovigilance (PV) Outsourcing Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Market Players (2016-2021) 4.3 Global Pharmacovigilance (PV) Outsourcing Average Price by Market Players (2016-2021) 5 Global Pharmacovigilance (PV) Outsourcing Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.1.2 Pharmacovigilance (PV) Outsourcing Key Players in North America (2016-2021) 5.1.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.1.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.2.2 Pharmacovigilance (PV) Outsourcing Key Players in East Asia (2016-2021) 5.2.3 East Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.2.4 East Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.3.2 Pharmacovigilance (PV) Outsourcing Key Players in Europe (2016-2021) 5.3.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.3.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.4.2 Pharmacovigilance (PV) Outsourcing Key Players in South Asia (2016-2021) 5.4.3 South Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.4.4 South Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.5.2 Pharmacovigilance (PV) Outsourcing Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.5.4 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.6.2 Pharmacovigilance (PV) Outsourcing Key Players in Middle East (2016-2021) 5.6.3 Middle East Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.6.4 Middle East Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.7.2 Pharmacovigilance (PV) Outsourcing Key Players in Africa (2016-2021) 5.7.3 Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.7.4 Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.8.2 Pharmacovigilance (PV) Outsourcing Key Players in Oceania (2016-2021) 5.8.3 Oceania Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.8.4 Oceania Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.9.2 Pharmacovigilance (PV) Outsourcing Key Players in South America (2016-2021) 5.9.3 South America Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.9.4 South America Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Pharmacovigilance (PV) Outsourcing Market Size (2016-2021) 5.10.2 Pharmacovigilance (PV) Outsourcing Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Pharmacovigilance (PV) Outsourcing Market Size by Type (2016-2021) 5.10.4 Rest of the World Pharmacovigilance (PV) Outsourcing Market Size by Application (2016-2021) 6 Global Pharmacovigilance (PV) Outsourcing Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Pharmacovigilance (PV) Outsourcing Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Pharmacovigilance (PV) Outsourcing Consumption by Countries 7 Global Pharmacovigilance (PV) Outsourcing Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Pharmacovigilance (PV) Outsourcing (2022-2027) 7.2 Global Forecasted Revenue of Pharmacovigilance (PV) Outsourcing (2022-2027) 7.3 Global Forecasted Price of Pharmacovigilance (PV) Outsourcing (2022-2027) 7.4 Global Forecasted Production of Pharmacovigilance (PV) Outsourcing by Region (2022-2027) 7.4.1 North America Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.3 Europe Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.7 Africa Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.9 South America Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Pharmacovigilance (PV) Outsourcing Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Application (2022-2027) 8 Global Pharmacovigilance (PV) Outsourcing Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.2 East Asia Market Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.3 Europe Market Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Countriy 8.4 South Asia Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.5 Southeast Asia Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.6 Middle East Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.7 Africa Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.8 Oceania Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.9 South America Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 8.10 Rest of the world Forecasted Consumption of Pharmacovigilance (PV) Outsourcing by Country 9 Global Pharmacovigilance (PV) Outsourcing Sales by Type (2016-2027) 9.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2016-2021) 9.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2022-2027) 10 Global Pharmacovigilance (PV) Outsourcing Consumption by Application (2016-2027) 10.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2016-2021) 10.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2022-2027) 11 Global Pharmacovigilance (PV) Outsourcing Manufacturing Cost Analysis 11.1 Pharmacovigilance (PV) Outsourcing Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Pharmacovigilance (PV) Outsourcing 12 Global Pharmacovigilance (PV) Outsourcing Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Pharmacovigilance (PV) Outsourcing Distributors List 12.3 Pharmacovigilance (PV) Outsourcing Customers 12.4 Pharmacovigilance (PV) Outsourcing Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00